Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Relife is a specialized dermatology and aesthetic medicine company headquartered in Italy and operating as a key division of the Menarini Group. The company provides a comprehensive 360-degree approach to skin health by bridging the gap between aesthetic procedures and clinical dermatological care. Its portfolio includes the Definisse range, which features high-quality hyaluronic acid fillers and synthetic resorbal threads for aesthetic rejuvenation, alongside therapeutic skincare lines like Relizema for dermatitis and Papulex for acne-prone skin. Relife focuses on evidence-based innovation and high-quality manufacturing to support healthcare professionals in plastic surgery and dermatology. The company is also known for its Relife Skin Academy, which provides scientific training and education to practitioners globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Relife Italia.